Cricketer Shardul Thakur battled through an extremely high fever while playing his Ranji Trophy match in Lucknow but had to ...

Amgen has shared (PDF) the first phase 3 data on its $400 million eczema drug, linking the | Amgen has shared the first phase ...

The U.S. Food and Drug Administration (FDA) has granted approval of 5 new prescription medications that are labeled for use ...

Amgen (NASDAQ:AMGN) shares were down 5% Wednesday, the day after the company reported Phase 3 results for its drugs ...

Inc. (Nasdaq: TSVT) today announced that the Company, in partnership with study sponsor Bristol Myers Squibb (BMS), will ...

Let’s face it: reading medical studies from the National Bureau of Economic Research (NBER) is about as thrilling as watching ...

See Contraindications. QT prolongation with concomitant dofetilide, quinidine, pimozide, cisapride, methadone, disopyramide, dronedarone, ranolazine. Concomitant ...

AEs included “reduced appetite, diarrhea, pyrexia, weariness, upper respiratory tract infection, lethargy, somnolence and bronchitis.” We also have Eisai’s Lorcaserin, which has been tested ...

of any grade in ≥7.5% of patients were nausea (18.9%), fatigue (18.9%), anemia (17.0%), abdominal pain (15.1%), constipation (13.2%), vomiting (13.2%), diarrhea (11.3%), pyrexia (9.4%), weight ...

Fluticasone furoate, vilanterol 50/25mcg, 100/25mcg, 200/25mcg; per inh; dry pwd for oral inh. Fluticasone furoate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity.

The most common AEs included diarrhea, cancer progression, anemia, hypokalemia, nausea, vomiting, and pyrexia, with placebo-treated patients reporting higher rates of diarrhea, nausea, and vomiting.

Amgen (AMGN) shares were down 5% Wednesday, the day after the company reported Phase 3 results for its drugs rocatinlimab and ...